Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-26 @ 2:07 PM
Study NCT ID:
NCT05309304
Status:
COMPLETED
Last Update Posted:
2022-10-12
First Post:
2022-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cefazolin PK Study 3g vs 2g
Sponsor:
Baxter Healthcare Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BXU567633
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None